A new study conducted by the MD Anderson Cancer Centre suggests that Bacillus Calmette–Guérin (BCG) vaccine, primarily used against tuberculosis, may reduce the Covid-19 intensity. The study suggests that the countries with BCG vaccine may be ahead in the Covid-19 fight. Does the BCG Vaccine boost immunity? Can it be a way forward? Watch as Dr Ashish M Kamat, MD Anderson Cancer Center and the author of the said study, answers these questions on News Today!
